STOCK TITAN
  1. Home
  2. Sec-filings
  3. ASMB
  4. [EFFECT] ASSEMBLY BIOSCIENCES, INC. SEC Filing

[EFFECT] ASSEMBLY BIOSCIENCES, INC. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 21, 2025 4:30 P.M.
Form: S-3
CIK: 0001426800
Company Name: ASSEMBLY BIOSCIENCES, INC.
File Number: 333-290866

Source: View Original Filing on SEC EDGAR

Assembly Bioscie

NASDAQ:ASMB

View ASMB Stock Overview →

ASMB Rankings

#3588 Ranked by Market Cap
N/A Ranked by Dividends
#269 Top Gainer

ASMB Latest News

Dec 22, 2025
Gilead Sciences Exercises Option to License Assembly Biosciences’ Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes
Dec 8, 2025
Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Studies of Long-Acting Helicase-Primase Inhibitor Candidates ABI-1179 and ABI-5366 Showing Reductions in Viral Shedding Rate and Virologically Confirmed Genital Lesion Rate in Recurrent Genital Herpes
Nov 10, 2025
Assembly Biosciences Reports Third Quarter 2025 Financial Results and Recent Updates
Nov 7, 2025
Assembly Biosciences Presents Positive Phase 1b Data for Next-Generation Capsid Assembly Modulator ABI-4334 at AASLD The Liver Meeting®
Oct 14, 2025
Assembly Biosciences Announces Upcoming Investor Conference Participation

ASMB Latest SEC Filings

Feb 9, 2026
[SCHEDULE 13G/A] ASSEMBLY BIOSCIENCES, INC. Amended Passive Investment Disclosure
Nov 21, 2025
[424B3] ASSEMBLY BIOSCIENCES, INC. Prospectus Filed Pursuant to Rule 424(b)(3)
Nov 10, 2025
[10-Q] ASSEMBLY BIOSCIENCES, INC. Quarterly Earnings Report
Nov 10, 2025
[8-K] ASSEMBLY BIOSCIENCES, INC. Reports Material Event
Oct 14, 2025
[S-3] ASSEMBLY BIOSCIENCES, INC. Shelf Registration Statement

ASMB Stock Data

447.15M
10.58M
Biotechnology
Pharmaceutical Preparations
Link
United States
SOUTH SAN FRANCISCO